NCT06250972View on ClinicalTrials.gov

Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2028

Conditions
Pancreatic Adenocarcinoma
Interventions
DRUG

Gemcitabine, Nab-paclitaxel, Irinotecan

continuing chemotherapy using the previous regimen until disease progression

RADIATION

Intensity-Modulated Radiation Therapy (IMRT)

Receive Intensity-Modulated Radiation Therapy (IMRT) after about 2\~6 cycles of chemotherapy.

Trial Locations (1)

200032

RECRUITING

Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER